Genomic screening in children: BabyScreen+

Gene: LAMP2

Green List (high evidence)

LAMP2 (lysosomal associated membrane protein 2, Ensemblv90)
EnsemblGeneIds (GRCh38): ENSG00000005893
EnsemblGeneIds (GRCh37): ENSG00000005893
OMIM: 309060, ClinGen, DECIPHER
LAMP2 is in 1 panel

1 review

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

X-linked dominant genetic disorder characterized by cardiomyopathy, skeletal myopathy, and neurocognitive deficits
Most men and many women with LAMP2 gene mutations will develop cardiac disease that includes hypertrophic cardiomyopathy and/or dilated cardiomyopathy, cardiac pre-excitation syndrome, and a propensity for arrhythmias. The prognosis is directly related to the severity of the cardiac disease, and many patients will die from sudden cardiac death. Males are typically more severely affected than females.

Early onset cardiomyoapthy and neurodevelopmental phenotype - reproductive utility to prevent multiple affected pregnancies. High-penetrance cardiomyopathy with high risk of arrhythmia and or transplant. Neurodevelopmental issues allow preparation and early childhood intervention.
- Ages of onset in Cohort studies and personal experience M 0.25–45 F2–58
- The family known to RCH/MMC is neonatal onset cardiomyopathy, symptomatic, potentially we should publish more formally, was presented at HGSA

International natural history study ongoing.
Expect therapy in next few years. Trials ongoing in Europe and US with therapy for CM and improvement in ND outcomes.
Rocket Pharmaceuticals Adeno-associated- vector-501 (RP-A501) (AAV9.LAMP2B), an investigational gene therapy product for DD and the first potential gene therapy for monogenic heart failure.

MODERATE actionability in paediatric patients by ClinGen.
Created: 14 Aug 2025, 3:01 p.m. | Last Modified: 14 Aug 2025, 3:24 p.m.
Panel Version: 0.40

Mode of inheritance
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)

Phenotypes
Danon disease, MIM# 300257

Details

Mode of Inheritance
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
Sources
  • Expert Review Green
  • Expert Review
Phenotypes
  • Danon disease, MIM# 300257
Tags
cardiac treatable
OMIM
309060
ClinGen
LAMP2
DECIPHER
LAMP2
Clinvar variants
Variants in LAMP2
Penetrance
None
Panels with this gene

History Filter Activity

Note: This information shows the history of the gene symbol, not the gene entity. Where the gene symbol for a gene has changed, this history may reference a different gene to the entry you are currently viewing.
14 Aug 2025, Gel status: 3

Added Tag, Added Tag

Zornitza Stark (Victorian Clinical Genetics Services)

Tag cardiac tag was added to gene: LAMP2. Tag treatable tag was added to gene: LAMP2.

14 Aug 2025, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: lamp2 has been classified as Green List (High Evidence).

14 Aug 2025, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: lamp2 has been classified as Green List (High Evidence).

14 Aug 2025, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

gene: LAMP2 was added gene: LAMP2 was added to Genomic screening in children: BabyScreen+. Sources: Expert Review Mode of inheritance for gene: LAMP2 was set to X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males) Phenotypes for gene: LAMP2 were set to Danon disease, MIM# 300257 Review for gene: LAMP2 was set to GREEN